Banco De Sabadell, S.A Amgen Inc Transaction History

Banco De Sabadell, S.A

$136 Million
Q2 2024

A detailed history of Banco De Sabadell, S.A transactions in Amgen Inc stock. As of the latest transaction made, Banco De Sabadell, S.A holds 7,562 shares of AMGN stock, worth $2.42 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

7,562

Previous 7,696 1.74%

Holding current value

$2.42 Million

Previous $2.19 Million 7.3%

% of portfolio

1.73%

Previous 1.63%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $35,208 - $42,787	-134 Reduced 1.74%	7,562 $2.35 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $32,264 - $38,947	-120 Reduced 1.54%	7,696 $2.19 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $2 Million - $2.25 Million	7,816 New	7,816 $2.25 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $1.51 Million - $1.71 Million	6,747 New	6,747 $1.52 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $1.3 Million - $1.45 Million	-5,647 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $61,395 - $67,919	280 Added 5.22%	5,647 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $154,330 - $176,617	776 Added 16.9%	5,367 $1.21 Million
Q3 2021 Nov 04, 2021	BUY	$212.27 - $248.7 $2,759 - $3,233	13 Added 0.28%	4,591 $978,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $50,920 - $56,492	218 Added 5.0%	4,578 $1.12 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $108,070 - $125,938	-487 Reduced 10.05%	4,360 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $2.58 Million - $3.07 Million	-11,903 Reduced 71.06%	4,847 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $759,327 - $844,434	3,236 Added 23.95%	16,750 $4.2 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $1.47 Million - $1.81 Million	7,450 Added 122.86%	13,514 $3.17 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1.6 Million - $2.12 Million	-8,767 Reduced 59.11%	6,064 $1.23 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $239,161 - $307,404	-1,264 Reduced 7.85%	14,831 $3.57 Million
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $716,984 - $859,097	-4,118 Reduced 20.37%	16,095 $3.13 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $433,419 - $508,066	-2,600 Reduced 11.4%	20,213 $3.73 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $133,120 - $150,055	736 Added 3.33%	22,813 $4.31 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.45 Million - $1.7 Million	8,143 Added 58.44%	22,077 $4.24 Million
Q3 2018 Nov 16, 2018	BUY	$185.29 - $208.89 $642,956 - $724,848	3,470 Added 33.16%	13,934 $2.9 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $1.55 Million - $1.74 Million	-9,336 Reduced 47.15%	10,464 $1.94 Million
Q1 2018 May 16, 2018	BUY	$169.43 - $198.0 $269,732 - $315,216	1,592 Added 8.74%	19,800 $3.39 Million
Q4 2017 Feb 16, 2018	BUY	$168.79 - $188.59 $3.07 Million - $3.43 Million	18,208	18,208 $3.17 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account

Banco De Sabadell, S.A Amgen Inc Transaction History